期刊文献+

取消药品加成对脑卒中患者费用和质量的影响研究 被引量:1

The Effect of Zero Markup Drug Policy on the Cost and Quality among Stroke Patients
下载PDF
导出
摘要 目的探索2017年4月我国东部某市取消药品加成后脑卒中住院患者医疗费用与医疗质量的变化。方法选取该市城镇职工医疗保险数据库2014年-2018年全部脑卒中住院病例,通过stata MP14.0软件进行描述性和线性回归分析。结果共纳入78208例脑卒中住院患者。改革后,脑卒中住院患者次均总费用、药品费用、耗材费用、住院时长、30 d再入院率显著下降(P<0.01),次均医生服务费用、护士服务费用、检查费用显著上升(P<0.01)。结论取消药品加成政策的实施,对降低医疗总费用、调整费用结构、缩短平均住院日有明显改善。未来应更关注患者出院评估,实行按绩效付费的支付制度,整合各级医疗资源,与价格调控政策形成合力,共同改善脑卒中医疗质量。 Objective To explore the changes of medical expenses and medical quality of stroke inpatients after zero markup drug policy in a city in eastern China in April 2017.Methods All hospitalized stroke cases from 2014 to 2018 were selected from the Urban Employee Basic Medical Insurance(UEBMI)database for descriptive and linear regression analysis using Stata MP14.0 software.Results A total of 78208 inpatients with stroke were included.After the reform,the average total cost per admission,drug cost,consumable cost,length of stay and 30-day readmission rate of stroke inpatients decreased significantly(P<0.01),while the doctor service cost,nurse service cost and examination cost increased significantly(P<0.01).Conclusion The zero-markup drug policy significantly reduced the total medical expenses,adjusted the cost structure and shortened the average length of stay.In the future,more attention should be paid to patient discharge evaluation,a pay-for-performance payment system should be implemented,and medical resources at all levels should be integrated to form synergy with price regulation policies to jointly improve the quality of stroke medical care.
作者 陈晰雯 曾剑英 卢铭 陈思远 周吴平 简伟研 CHEN Xiwen;ZENG Jianying;LU Ming(Department of Health Policy and Management, School of Public Health, Peking University, Beijing, 100191, China)
出处 《中国卫生质量管理》 2021年第5期23-25,39,共4页 Chinese Health Quality Management
基金 美国中华医学基金会(CMB)资助(CMB-OC 16-259)。
关键词 医疗费用 医疗质量 药品加成 脑卒中 Medical Expenses Medical Quality Drug Markups Stroke
  • 相关文献

参考文献4

二级参考文献29

  • 1宁宪嘉,王景华,李志尊.天津市城乡居民脑卒中流行病学调查6年前瞻性研究[J].中华流行病学杂志,1995,16(5):281-284. 被引量:5
  • 2MURRAY CJL, LOPEZ AD. Measuring the Global Burden of Disease [ J]. New England Journal of Medicine, 2013, 369 (5) :448-457.
  • 3FEIGIN, VL, KRISHNAMURTHI RV, PARMAR P, et al. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study [ J ]. Neuroepideroiology, 2015, 45 (3) : 161-176.
  • 4Global Burden of Disease Study 2013. Global Burden of Disease Study 2013 ( GBD 2013 ) Results by Location, Cause, and Risk Factor. Seattle, United States: Institute for Health Metrics and Evaluation ( IHME), 2016.
  • 5KRISHNAMURTHI RV, MORAN AE, FEIGIN VL, et al. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study[ J]. Neuroepidemiology, 2015, 45 (3) : 190-202.
  • 6KRISHNAMURTHI RV, DEVEBER G, FEIGIN ~L, et al. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Children and Youth Aged 0 ~ 19 Years: Data from the Global and Regional Burden of Stroke 2013 [ J]. Neuroepidemiology, 2015, 45 (3) : 177-189.
  • 7BARKER-COLLO S, BENNETT DA, KRISHNAMURTHI RV, et al. Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013 [ J]. Neuroepidemiology, 2015, 45(3) :203-214.
  • 8FEIGIN VL,MENSAH GA, NORRVING B, et al. Atlas of the Global Burden of Stroke ( 1990-2013 ) : The GBD 2013 Study [ J ]. Neuroepidemiology, 2015, 45 (3) :230-236.
  • 9刘晓婷.我国城乡居民脑卒中疾病负担研究[J],中国疾病预防控制中心,2011.
  • 10胡盛寿.中国心血管病报告[M].北京:中国大百科全书出版社,2015.

共引文献360

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部